Shuang Xu, PhD

Scientist
Certara, Inc.

Poster(s):

• (M-033) Population Pharmacokinetic Analysis of Possible Drug-Drug Interactions between Mouse Double Minute 2 (MDM2) Inhibitor Navtemadlin and the Bruton's Tyrosine Kinase (BTK) Inhibitor Acalabrutinib in Patients with R/R CLL or R/R DLBCL
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT